Legend Biotech (LEGN) Interest & Investment Income (2024 - 2026)
Legend Biotech's (LEGN) quarterly Interest & Investment Income came in at $7.3 million in Q1 2026, down 39.67% YoY from $12.1 million in Q1 2025, and down 7.59% on a QoQ basis from $7.9 million in Q4 2025.
Legend Biotech (LEGN) Interest & Investment Income (2024 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 3 years of Interest & Investment Income data on file, last reported at $7.3 million in Q1 2026.
- Quarterly Interest & Investment Income fell 39.67% year-over-year to $7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.3 million (down 40.66% YoY) and the FY2025 annual result came in at $40.1 million, down 34.48% from the prior year.
- Interest & Investment Income retreated to $7.3 million in Q1 2026, from $7.9 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $17.0 million in Q2 2024 to a low of $7.3 million in Q1 2026.
- A 3-year average of $12.1 million and a median of $12.1 million in 2025 frame the typical range for Interest & Investment Income.
- The widest YoY moves for Interest & Investment Income: up 12.76% in 2025, down 42.34% in 2025.
- Tracing LEGN's Interest & Investment Income over 3 years: stood at $13.7 million in 2024, then sank by 42.34% to $7.9 million in 2025, then declined by 7.59% to $7.3 million in 2026.
- The last three Interest & Investment Income figures came in at $7.3 million (Q1 2026), $7.9 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.60 Mn |
| Mar 31, 2026 | 7.30 Mn |
| Dec 31, 2025 | 7.90 Mn |
| Sep 30, 2025 | 9.66 Mn |
| Jun 30, 2025 | 10.43 Mn |
| Mar 31, 2025 | 12.10 Mn |
| Dec 31, 2024 | 13.70 Mn |
| Sep 30, 2024 | 16.63 Mn |
| Jun 30, 2024 | 17.05 Mn |
| Mar 31, 2024 | 13.87 Mn |